Genu Recurvatum Companies
Genu Recurvatum refers to a medical condition characterized by hyperextension of the knee joint, causing the leg to bend backward. It's not a company or a business term.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Genu Recurvatum Companies Update
May 2023: Arthrex, a global leader in minimally invasive orthopedic technology, launched ACLTear.com, a new patient-focused website that illustrates the science of anterior cruciate ligament (ACL) injuries, highlights the benefits of knee preservation technology, and connects patients with surgeons performing advanced, minimally invasive ACL procedures. Arthrex, the innovation leader in arthroscopic surgery, is shaping the future of ACL injury treatment. ACLTear.com is a fantastic educational site for patients looking for in-depth information based on substantial orthopedic research and real-world patient experiences. Arthrex has introduced two minimally invasive ACL preservation solutions: the ACL Repair TightRope® implant and the SwiveLock® ACL Repair Kit, the first of its type in the orthopedic industry to get FDA approval.
June 2022: OrthoPediatrics Corp., a company dedicated solely to the advancement of pediatric orthopedics, was pleased to announce the acquisition of Vilex in Tennessee, Inc. and Orthex, LLC, as well as its Orthex Hexapod circular fixation technology and proprietary CORA-based x-ray planning software, for a total of $60 million in cash and stock. The acquisition will be funded in part by $30 million in additional financing given by Squadron Capital LLC on terms similar to the other loans granted by Squadron Capital LLC to OrthoPediatrics. Vilex is largely a foot and ankle surgery firm with a product portfolio aimed at juvenile and adult patients that earned $11.8 million in total revenue, the majority of which came from the United States, and around $2.9 million in net income. Orthex is used to treat congenital abnormalities and limb length disparities in children, including fibula and tibia hemimelia, radial clubhand, ankle equinus, Blount's disease, genu recurvatum, and multiapical deformities.
List of Genu Recurvatum Key companies in the market
- DePuy Synthes Companies (Part of Johnson & Johnson Services, Inc.)
- Globus Medical, Inc.
- Medtronic plc
- NuVasive, Inc.
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Inc
Genu Recurvatum Market Highlights:
Genu Recurvatum Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
